Joey Mattingly, PharmD, MBA, PhD

ORCID logo http://orcid.org/0000-0001-7786-5780

About Dr. Mattingly:

After graduating from the University of Kentucky College of Pharmacy and Gatton College of Business and Economics, Dr. Mattingly dove directly into pharmacy practice for The Kroger Company as an EPRN super trainer, facilitating the implementation of a new pharmacy information system software to more than 40 pharmacies.   After completion of the pharmacy system rollout, Dr. Mattingly managed four different Kroger Pharmacy locations (L292, L780, L366, and L389) between 2010 and 2012, revamping operations at each location to improve multiple business and patient care activities.  Dr. Mattingly was promoted within Kroger to serve as District 6 Pharmacy Coordinator in the Mid-South Division, based in Carbondale, Illinois, overseeing operations for 12 pharmacies.

In 2013, Dr. Mattingly left The Kroger Company to lead Indianapolis operations as general manager for a start-up long-term care pharmacy company called AlixaRx, providing pharmacy services and remote automated dispensing systems to 23 skilled nursing facilities (SNFs) across Indiana, Kentucky, and Ohio. He currently serves as an associate professor in the Department of Pharmaceutical Health Services Research at the University of Maryland School of Pharmacy, where he teaches business strategy to students in the professional program and is a strategic consultant for the University of Maryland Medical Center Department of Pharmacy. In 2016, Dr. Mattingly was selected as the graduating class Teacher of the Year.

In addition to his work as a faculty member, he serves as the Director of Operations for the PATIENTS Program. Dr. Mattingly is also passionate about policy and parliamentary procedure and is the Speaker of the House of Delegates and Board of Trustee for the American Pharmacists Association.  He has previously served the American Pharmacists Association Academy of Student Pharmacists (APhA-ASP), the Kentucky Pharmacists Association (KPhA), and Phi Lambda Sigma Pharmacy Leadership Society as speaker of the house.

Research Interests:

Dr. Mattingly’s primary research interests include incorporating the patient voice in health economics and outcomes research. Through patient engagement, Dr. Mattingly hopes to improve methods for value assessment of new pharmaceuticals and to improve health outcomes by changing the structure and processes involved in patient care delivery.

Scholarship

 Publications in Refereed/Peer Reviewed Journals (* indicates mentored student, underline indicates corresponding author)

  1. Mattingly II TJ, Kiser L, Hill S, Briggs EC, Trunzo CP, Zafari Z, Betancourt TS. Unseen Costs: Estimated Direct and Indirect Impact of US Immigration Policies on Child Health and Well-Being. Journal of Traumatic Stress. Online ahead of print August 13, 2020. DOI: 10.1002/jts.22576 Available: https://onlinelibrary.wiley.com/doi/10.1002/jts.22576
  2. Linthicum M, dosReis S, Slejko JF, Mattingly II TJ, Bright J. Guiding the Evolution of patient-informed HEOR. The Patient. Online ahead of print August 28, 2020. Available: https://doi.org/10.1007/s40271-020-00446-3
  3. Livingston AN*, Mattingly II TJ. Drug and medical device product failures and the stability of the pharmaceutical supply chain. J Am Pharm Assoc. Online ahead of print July 16, 2020. DOI: 10.1016/j.japh.2020.07.005. Available: https://www.japha.org/article/S1544-3191(20)30325-3/fulltext
  4. Mattingly II TJ, Love BL, Khokhar B. Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review. PharmacoEconomics. 2020;38:927-939. DOI: 10.1007/s40273-020-00933-3. Available at: https://rdcu.be/b4S7m
  5. Mattngly II TJ, Shere-Wolfe K. Clinical and economic outcomes evaluated in Lyme Disease: a systematic review. Parasites & Vectors. 2020;13:34. DOI: 0.1186/s13071‑020‑04214‑y. Available: https://rdcu.be/b5xIK
  6. Mattingly II TJ. The economics of drug allergy. Current Opinion in Allergy & Clinical Immunology. Online ahead of print May 20, 2020. DOI: 10.1097/ACI.0000000000000651. Available: https://journals.lww.com/co-allergy/Abstract/9000/The_economics_of_drug_allergy.99068.aspx
  7. Mattingly II TJ. Elimination of hepatitis C virus infection in Canada is achievable, but is the rest of the world ready to join in this effort? JAMA Network Open. 2020;3(5):e204355. DOI:10.1001/jamanetworkopen.2020.4355 Available at: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2765569?resultClick=3
  8. Mattingly II TJ, Heil EL. The Economics of Penicillin Allergy Testing: Still Scratching the Value Surface. Clinical Infectious Diseases. Online ahead of print, February 28, 2020. Available at: https://doi.org/10.1093/cid/ciaa195
  9. Mattingly II TJ, Hogue MD. Pharmacy’s Call for Authorities to Aggressively Enforce Laws Addressing Price Gouging. J Manag Care Spec Pharm. 2020;April 24:1-4. DOI: 10.18553/jmcp.2020.20166. Available at: https://www.jmcp.org/doi/10.18553/jmcp.2020.20166
  10. Mattingly II TJ, Love BL. Changes in cost-effectiveness for chronic hepatitis C virus pharmacotherapy: The case for continuous cost-effectiveness analyses. J Manag Care Spec Pharm. 2020;26(7):879-886. DOI: 10.18553/jmcp.2020.26.7.879. Available at: https://www.jmcp.org/doi/full/10.18553/jmcp.2020.26.7.879?mobileUi=0
  11. Desai B, Mattingly II TJ, van den Broek R, Pham N, Frailer M, Yang J, Perfetto EM. Peer Review and Transparency in Evidence-Source Selection in Value and Health Technology Assessment. Value in Health. Online ahead of print, April 6, 2020. Available at: https://doi.org/10.1016/j.jval.2020.01.014
  12. Tran D, Mattingly II TJ, Sera L. Building confidence: Three-year evaluation of systematic progression of prescription verification on students’ confidence during IPPE. Currents in Pharmacy Teaching and Learning. 2020;12(4):388-394. DOI: 10.1016/j.cptl.2019.12.036. Available: https://www.sciencedirect.com/science/article/pii/S1877129719303132
  13. Mattingly II TJ, Slejko JF, Onukwugha E, Perfetto EM, Kottilil S, Mullins CD. Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis. Pharmacoeconomics. 2020;38:233-242. DOI: 10.1007/s40273-019-00864-8. Available: https://rdcu.be/bYbA7
  14. Slejko JF, Mattingly II TJ, dosReis S. The Future of Patient-Driven Healthcare Evaluation: The Patient-informed Reference Case. Value in Health. 2019;22(5):545-8. DOI: 10.1016/j.jval.2019.02.003.
  15. Mattingly II TJ. Before we talk about student debt cancelation, can we talk about the interest rates? Am J Pharm Educ. 2019;83(9):Article 7761. Available: https://www.ajpe.org/content/83/9/7761
  16. Mattingly II TJ, Slejko JF, Perfetto EM, Kottilil S, Mullins CD. What Matters Most for Treatment Decisions in Hepatitis C: Effectiveness, Costs, and Altruism. The Patient. 2019;12:631-638. DOI: 10.1007/s40271-019-00378-7. Available: https://link.springer.com/article/10.1007%2Fs40271-019-00378-7
  17. Dahmane E, Tang K, Gobburu J, Mattingly II TJ, Reed BN, See VY, Ayres J, Ivaturi V. Clinical Pharmacology Driven Translational Research to Optimize Bedside Therapeutics of Sotalol Therapy. Clin Transl Sci. 2019. Online ahead of print, July 22, 2019. DOI: 10.1111/cts.12670. Available: https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1111/cts.12670
  18. Kennedy D, Harrell K, Lodise N, Mattingly II TJ, Norenberg J, Ragucci K, Ranelli P, Stewart A. Current Status and Best Practices of Shared Governance within US Pharmacy Programs. Am J Pharm Educ. 2020;84(7):ajpe7281. DOI: 10.5688/ajpe7281 Available: https://www.ajpe.org/doi/abs/10.5688/ajpe7281
  19. Smith T, Mattingly TJ, Slabaugh L. Improving health determinants outside of the clinic does not mean outside of clinical science. Healthcare. 2019. Online ahead of print June 27, 2019. DOI: 10.1016/j.hjdsi.2019.06.001. Available at: https://www.sciencedirect.com/science/article/pii/S2213076419301484?via%3Dihub
  20. Mattingly II TJ, Abdelwadoud M, Mullins CD, Eddington ND. Pharmapreneur – Defining a Framework for Entrepreneurship in Pharmacy Education. Am J Pharm Educ. 2019;83(10):Article 7548. Available: https://www.ajpe.org/doi/abs/10.5688/ajpe7548
  21. Mattingly II TJ. 2019 Prescott Lecture: The Case for Authentic Leadership. J Am Pharm Assoc. 2019;59:e12-e15. DOI: 10.1016/j.japh.2019.05.018. Available: https://www.japha.org/article/S1544-3191(19)30237-7/fulltext.
  22. Urick BY, Mattingly II TJ, Mattingly AN. Relationship between Regulatory Barriers to Entry and Pharmacy Technician Wages. Research in Social and Administrative Pharmacy. Online ahead of print May 17, 2019. DOI: 10.1016/j.sapharm.2019.05.003.
  23. Reed BN, Klutts A, Mattingly II TJ. Leadership in Pharmacy: A Systematic Review of Definitions, Competencies, and Assessment Methods. Am J Pharm Educ. 2019;83(9): Article 7520. DOI: 10.5688/ajpe7520. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920635/
  24. Kaufman HL, Atkins MB, Subedi P, Wu J, Chambers J, Mattingly TJ, Campbell JD, Allen J, Ferris AE, Schilsky R, Danielson D, Lichtenfeld JL, House L, Selig W. The Promise of Immuno-Oncology: Implications for Defining the Value of Cancer Treatment. J Immunother Cancer. 2019;7(1):129. DOI: 10.1186/s40425-019-0594-0.
  25. Mattingly II TJ, Pandit NS, Onukwugha E. Burden of Co-Infection: A cost analysis of human immunodeficiency virus in a commercially insured hepatitis C virus population. Infect Dis Ther. 2019;8(2):219-228. doi: 10.1007/s40121-019-0240-7. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522558/
  26. Mattingly II TJ, Meninger S, Heil EL. Penicillin skin testing in methicillin-sensitive staphylococcus aureus bacteremia: A cost-effectiveness analysis. PLoS ONE. 2019;14(1): e0210271. DOI: https://doi.org/10.1371/journal.pone.0210271
  27. Mattingly II TJ, Nong K. Implementing a health confidence tool at time of discharge. Patient. Online ahead of print October 30, 2018. https://doi.org/10.1007/s40271-018-0343-3
  28. Mattingly II TJ, Levy JF, Slejko JF, Onwudiwe NC, Perfetto EM. Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References? PharmacoEconomics. 2018;36(9):1093-1099. DOI: 10.1007/s40273-018-0667-9.
  29. Mattingly II TJ, Mullins CD, Melendez DR, Boyden K, Eddington ND. Entrepreneurship in Pharmacy Practice and Education: A Systematic Review. Am J Pharm Educ. Online ahead of print August 24, 2018. DOI: 10.5688/ajpe7233
  30. Mattingly II TJ. Is there room for efficiency in pharmacy education? Am J Pharm Educ. 2018;82(9): Article 7271. DOI: 10.5688/ajpe7271
  31. Mattingly II TJ. APhA adopts actionable policy once again. J Am Pharm Assoc. 2018;58(4):334-5. DOI: 10.1016/j.japh.2018.06.007
  32. Mattingly AN, Mattingly II TJ. Regulatory burden and salary for pharmacy technicians in the United States. Research in Social and Administrative Pharmacy. Online ahead of print July 11, 2018. DOI: 10.1016/j.sapharm.2018.07.009
  33. Mattingly II TJ, Fulton A, Lumish R, Williams A, Yoon S, Yuen M, Heil EM. The cost of self-reported penicillin allergy: a systematic review. JACI: In Practice. 2018;6(5): 1649-1654.e4. DOI: 10.1016/j.jaip.2017.12.033
  34. Wu T, Williams C, Vranek K, Mattingly II TJ. Using 340B Drug Discounts to Provide a Financially Sustainable Medication Discharge Service. Research in Social and Administrative Pharmacy. Online March 27, 2018. DOI: 10.1016/j.sapharm.2018.03.065
  35. Mattingly II TJ. Measuring pharmacy technician impact on desired outcomes. J Am Pharm Assoc. 2018;58(1):8-9. DOI: 10.1016/j.japh.2017.12.002.
  36. Mattingly AN, Mattingly II TJ. Advancing the role of the pharmacy technician: A systematic review. J Am Pharm Assoc. 2018;58(1):94-108. DOI: 10.1016/j.japh.2017.10.015.
  37. Mattingly II TJ, Simoni-Wastila L. Patient-Centered Drug Approval: The role of patient advocacy in the drug approval process. Journal of Managed Care & Specialty Pharmacy. 2017;23(10):1078-82. DOI: 10.18553/jmcp.2017.23.10.1078
  38. Mattingly II TJ, Slejko JF, Mullins CD. Hepatitis C treatments are cost-effective – but compared to what? Annals of Pharmacotherapy. 2017;51(11):961-9. DOI: 10.1177/1060028017722007
  39. Yu J, Pincus KJ, Mattingly II TJ. Service description and descriptive analysis for an interprofessional discharge clinic (IDC) with a primary care practice. Journal of Interprofessional Care. 2017;31(6):771-3. DOI: 10.1080/13561820.2017.1347611
  40. Mattingly II TJ, Perfetto EM, Johnson S. Engaging hepatitis C infected patients in cost-effectiveness analyses: a literature review. Hepatology. 2018;67(2):774-81. DOI: 10.1002/hep.29482.
  41. Dunn EE*, Vranek K, Hynicka L, Gripshover J, Potosky D, Mattingly II TJ. Improving prior authorization efficiency in the treatment of hepatitis C virus (HCV) in an academic medical center. Quality Management in Health Care. 2017;26(3):136-9. DOI: 10.1097/QMH.0000000000000137
  42. Mattingly II TJ, Ulbrich TR. Evaluating the Changing Financial Burden for Graduating Pharmacists. Am J Pharm Educ. 2017;81(7): Article 5990. DOI: 10.5688/ajpe5990
  43. Mattingly II TJ, Romanelli F, Cain J, Schlesselman LS. Measuring Up: Defining the Quality of PharmD Programs. Am J Pharm Educ. Epub ahead of print September 19, 2017.
  44. Hindman FM*, Bukowitz A*, Reed BN, Mattingly II TJ. No Filter: A characterization of #pharmacists posts on Instagram. J Am Pharm Assoc. 2017;57(3):318-325. DOI: 10.1016/j.japh.2017.01.009.
  45. Mattingly II TJ, Gaballah M*. 340B Overview: The Evolution of Drug Price Discounts in the United States. Pharmacy Times Continuing Education. November 10, 2016.
  46. Mattingly II TJ, Heil EL, Hoke KS. Exploring the case for eminent domain of hepatitis C virus treatment patents. Journal of Health Care for the Poor and Underserved. 2017;28(2):621-625. DOI: 1353/hpu.2017.0062
  47. Mattingly II TJ, Mullins CD, Onukwugha E. Publication of Cost-of-Illness Studies: Does Methodological Complexity Matter? Pharmacoeconomics. 2016;34(10):1067-70. DOI: 1007/s40273-016-0438-4.
  48. Feemster AA, Mattingly II TJ. Multiple Bosses: Challenges and suggestions to improve organizational environments in academic settings. INNOVATIONS in pharmacy. 2016; 7(2):7.
  49. Mattingly II TJ, Tom SE, Stuart B, Onukwugha E. Examining patient-provider relationship (PPR) quality and patient activation. Aging Clinical and Experimental Research. 2016; epub ahead of print. DOI: 10.1007/s40520-016-0600-z
  50. Miklich MA, Reed BN, Mattingly II TJ, Haines ST. Beliefs and behaviors of professionally engaged pharmacists. Journal of the American Pharmacists Association. 2016; 56(4):405-11. DOI: 10.1016/j.japh.2016.03.011.
  51. Mattingly II TJ. A review exploring the relationship between nursing home staffing and antipsychotic medication use. Neurol Ther. 2015;1-7. DOI: 1007/s40120-015-0032-2.
  52. Mattingly II TJ. Innovative patient care practices using social media. J Am Pharm Assoc. 2015; 10:e295-300. DOI: 1331/JAPhA.2015.14171.
  53. Mattingly II TJ. Rescheduling of Combination Hydrocodone Products: Problems for Long-Term Care Practitioners. The Consultant Pharmacist. 2015; 30(1):13-7. DOI: 10.4140/TCP.n.2015.13.
  54. Yu JY*, Mattingly II TJ, Pinus KJ. Pharmacist interventions in transitions of care. MSHP Pharmascript. 2015;39(2):4-6.
  55. Mattingly II TJ, Cain J, Fink JL. Pharmacists on Facebook: online social networking and the profession. J Am Pharm Assoc. 2010;50(3):424-427. DOI: 10.1331/JAPhA.2010.08174.
  56. Weitzel KW, Tisdale JE, Mattingly J. APhA2009 House of Delegates: Serving the Association and the profession. J Am Pharm Assoc. 2009;49(4):474-80. DOI:10.1331/JAPhA.2009.09520.
  57. Lutz EM, Rovers J, Mattingly J, Reed BN. Pharmacy practice around the world. J Am Pharm Assoc. 2009;49(1):4-11. DOI:10.1331/JAPhA.2009.09500.

Other Publications and Related Activities

 Book Chapters

  1.  Mattingly TJ, Piasick P. Oral contraceptives. In: Smith KM, Riche D, Henyan N, eds. Clinical Drug Data. 11th New York, NY: McGraw Hill; 2010:1247-51.

 Publications in non-referred journals

  1.  Yu JY*, Mattingly TJ, Pinus KJ. Pharmacist interventions in transitions of care. MSHP Pharmascript. 2015;39(2):4-6.
  2. Mattingly J. Social Networking: Issues addressing the impact of online social media on pharmacy organizations and the profession. Indiana Pharmacist. 2013 (March).
  3.  Mattingly J. Era of Connection: Social media and its impact on pharmacy. Student Pharmacist Magazine. 2013 (April/May).
  4.  Mattingly J. Understanding Drug Pricing. US Pharmacist (Generic Drug Supplement); 2012:72.
  5.  Mattingly J. Taking the plunge: Diving head first into a career after graduation. Student Pharmacist Magazine. 2012 (September/October).
  6.  Mattingly J.Will FTC revisit PBM ownership of mail-order pharmacies post-merger? Pharmacy Today. 2012 (May).
  7.  Mattingly TJ, Yusuf JW, Fink JL. Turning that great idea into a thriving business. Pharmacy Times (online edition). 2009 (February).
  8.  Mattingly J. Education abroad: Developing as a health professional to benefit our healthcare system here in the US. Kentucky Pharmacist. 2008 (November).
  9.  Mattingly J. Grassroots advocacy: creating change from the ground up. Student Pharmacist. 2008 (July/August).
  10.  Mattingly TJ. Can you explain pharmacy to an eighth grader? Drug Topics (Digital Edition). 2008 (February).
  11.  Mattingly TJ. PharmD/MBA Degree: A perfect combination for me. Pharmacy Careers. 2008 (January).

Special Lecture (Invited)

  1.  Financial & Ethical Implications of New HCV Therapy. Mattingly J. Maryland Society of Health-System Pharmacists Spring Seminar. Baltimore, Maryland. May 2015. [State]. Continuing Education (Invited).
  2.  Dollars and Per-cents: Understanding Pharmacy Finance. Mattingly J. Kappa Psi Pharmaceutical Fraternity Spring Province Meeting. Baltimore, Maryland. April 2015. [Regional]. Continuing Education (Invited).
  3.  Navigating Recruitment Forums and Negotiation Strategies. Mattingly J. University of Maryland Residency Program Professional Development Series. Baltimore, Maryland. January 2015. [Local]. Lecture (Invited).
  4.  National Community Pharmacists Association Business Plan Workshops I & II. Mattingly J. University of Maryland NCPA Chapter. Baltimore, Maryland. January 2015. [Local]. Workshop Leader (Invited).
  5.  Real World Financial Planning. Winslow C, Mattingly J. American Pharmacists Association ASP/NPN Webinar Series. Online. July 2014. [National]. Lecture (Invited).
  6.  Leadership beyond pharmacy school. Mattingly J. University of Kentucky College of Pharmacy Thomas S. Foster Leadership Day. Lexington, Kentucky. October 2013. [State]. Lecture (Invited).
  7.  Friend Request: E-professionalism and social media in the pharmacy. Mattingly J. American Pharmacists Association Annual Meeting. Los Angeles, California. March 2013. [National]. Continuing Education (Invited).
  8.  Pharmacists on Facebook: Issues addressing the impact of online social media on corporate pharmacy and the profession. Mattingly J, Cain J. The Kroger Company Mid South Division Pharmacy Meeting. New Albany, Indiana. August 2010. [Regional]. Continuing Education (Invited).
  9.  Social Media and Pharmacy: E-professionalism, Impression Management, & Opportunities. Cain J, Mattingly J. University of Charleston School of Pharmacy. Charleston, West Virginia. March 2010. Lecture (Invited).
  10.  Public Speaking and Networking. Mattingly J. University of Kentucky Phi Lambda Sigma Chapter. Lexington, Kentucky. January 2010. [Local]. Workshop Leader (Invited).
  11.  E-Professionalism: The emerging impact of social media on pharmacy professionals. Cain J, Dabestani A, Dotter E, Mattingly J. American Society of Health-System Pharmacy Midyear Clinical Meeting. December 2009. [National]. Panel Discussion (Invited).
  12.  A Rotation in Canada, eh? Mattingly J. University of Kentucky Convocation Series. Lexington, Kentucky. December 2008. [Local]. Lecture (Invited).
  13.  Student Political Advocacy Workshop. Mattingly J. American Pharmacists Association Academy of Student Pharmacist Midyear Regional Meeting. Cincinnati, Ohio. October 2008. [Regional]. Lecture (Invited).
  14.  APhA-ASP Outreach. Mattingly J. American Pharmacists Association Academy of Student Pharmacist national officer outreach presentations delivered to the University of Texas, South Carolina College of Pharmacy, and James L. Winkle College of Pharmacy. Austin,Texas; Columbia, South Carolina; Cincinnati, Ohio. October 2008. [Regional]. Lecture (Invited).
  15.  Health Literacy: Improving your patient’s understanding. Mattingly J. Communications and Public Education Working Group (CPEWG) within the British Columbia Ministry of Health. Victoria, British Columbia, Canada. May 2008. [International]. Lecture (Submitted).
  16.  Expanding the Role: The advancement of pharmacy practice to meet patient needs and improve healthcare quality. Mattingly J. Pharmaceutical Services Division within the British Columbia Ministry of Health. Victoria, British Columbia, Canada. May 2008. Lecture (Submitted).

Teaching

Course name Course Prefix and Number No. of Credits No. of enrolled students Type of students Your Role in the Course Number of Lectures Taught Year(s)Taught(E.g. 2009-2010)
Pharmacy Practice Management PHAR562 3 160 PharmD Additional Faculty 9 2014
Abilities Lab 6 PHAR567 1 160 PharmD Course Manager 5 2015
Abilities Lab 1 PHAR505 2 160 PharmD Instructor 4 2014
Professionalism & Ethics in Pharmacy Practice PHAR507 2 160 PharmD Instructor 1 2015

Service

American Pharmacists Association

  • APhA-APRS Communications Standing Committee (2014 – Present)
  • Policy Committee Member (2013 – 2014)
  • New Practitioner Network Standing Committee Member (2012 – 2013)
  • Editorial Advisory Board Member, Pharmacy Today (2009 – 2012)
  • National Speaker of the House, Student Academy (2008 – 2009)
  • Political Action Committee Board of Governors Member (2008 – 2009)
  • Foundation Advisory Committee (2008 – 2009)
  • Vice Chair, National Standing Committee on Communications (2007 – 2008)
  • Chapter President, University of Kentucky (2007 – 2008)
  • Editorial Advisory Board Member, Student Pharmacist Magazine (2007 – 2008)

Kentucky Pharmacists Association

  • Board of Directors Member (2009 – 2012)
  • Chair, Organizational Affairs Committee (2011 – 2012)
  • Policy Review Committee Member (2011 – 2012)
  • Parliamentarian (2011 – 2012)
  • Louisville Heath Information Exchange Committee (2010 – 2012)
  • Speaker of the House (2010 – 2011)

University of Kentucky College of Pharmacy

  • Development Committee Member (2012 – Present)
  • Curriculum Committee Member (2011 – 2012)
  • College Admissions Committee (2005 – 2009)
  • College Senator (2006 – 2008)
  • Chair, Student Advisory Council (2006 – 2008)

Jefferson County Academy of Pharmacy

  • President (2010 – 2012)
  • Vice President (2009 – 2010)

Kappa Psi Pharmaceutical Fraternity

  • Faculty Advisor, Sigma Chapter (2014 – Present)
  • Chair, Proxy Voting Task Force (2013 – Present)
  • National Parliamentarian (2011 – 2012)
  • Kentucky Graduate Chapter Member (2009 – Present)
  • Upsilon Chapter Member (2006 – 2009)

Phi Lambda Sigma Pharmacy Leadership Society

  • National Speaker of the House (2007 – 2008)
  • Chi Chapter Member (2006 – 2009)